Longitudinal Follow-Up and Outcomes for Chinese Patients with Stage 1-4 Chronic Kidney Disease.

Journal: Kidney diseases (Basel, Switzerland)
Published Date: Oct 27, 2021

Abstract

INTRODUCTION: Understanding heterogeneity in the prognosis of chronic kidney disease (CKD) has implications in management of patients. We aimed to evaluate the comparative risk of end-stage kidney disease (ESKD), cardiovascular (CV) events, and death among patients with CKD in China.

Authors

  • Jinwei Wang
    Weifang Ensign Industry Co., Ltd Weifang 250353 China.
  • Jicheng Lv
    Renal Division, Department of Medicine, Peking University First Hospital, Beijing, China.
  • Kevin He
    Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor, Michigan, USA.
  • Fang Wang
    Key Laboratory of Intelligent Computing and Information Processing of Ministry of Education and Hunan Key Laboratory for Computation and Simulation in Science and Engineering, Xiangtan University, Xiangtan, China.
  • Bixia Gao
    Renal Division, Department of Medicine, Peking University First Hospital, Beijing, China.
  • Ming-Hui Zhao
    Renal Division, Department of Medicine, Peking University First Hospital, Beijing, China.
  • Luxia Zhang
    Renal Division, Department of Medicine, Peking University First Hospital, Beijing, China.

Keywords

No keywords available for this article.

External Resources

Popular Topics
Recent Journals